Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
crawled date : 2021 - 11 - 09 source : Www.biospace.com save search
BioIVT to Showcase Use of a Sandwich-cultured Human Hepatocyte Model to Study Drug-Drug Interactions
Published: 2021-11-09 (Crawled : 22:00) - biospace.com/
ESPR | $2.115 1.2% 1.18% 5.4M
|
Health Technology
|
| O: -2.08%
H: 3.03%
C: -0.61%
drug
Chemomab to Present at Stifel 2021 Virtual Healthcare Conference
Published: 2021-11-09 (Crawled : 21:00) - biospace.com/
CMMB | $0.67 0.02% 3.4K
|
Manufacturing
| Email alert
Add to watchlist
conference
Zentalis Pharmaceuticals to Present at Two Upcoming Investor Conferences
Published: 2021-11-09 (Crawled : 21:00) - biospace.com/
ZNTL | $11.76 -6.44% -6.89% 850K
|
Health Technology
|
| O: -0.09%
H: 0.0%
C: 0.0%
conference
Accuray To Participate at Stifel 2021 Virtual Healthcare Conference
Published: 2021-11-09 (Crawled : 21:00) - biospace.com/
ARAY | $2.2 -0.9% -0.91% 290K
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: 0.0%
conference
Bio-Techne To Present At The Stifel 2021 Virtual Healthcare Conference
Published: 2021-11-09 (Crawled : 21:00) - biospace.com/
TECH | $63.48 -0.33% -0.33% 980K
|
Health Technology
|
| O: 1.59%
H: 0.32%
C: -0.76%
conference
RedHill Biopharma to Present at H.C. Wainwright 7th Annual Israel Conference and German Equity Forum (EKF) 2021
Published: 2021-11-09 (Crawled : 21:00) - biospace.com/
RDHL | $0.415 -2.99% -3.08% 190K
|
Health Technology
|
| O: -2.16%
H: 0.0%
C: 0.0%
israel biopharma conference germany
TELA Bio Announces Publication of 12-Month Results from the BRAVO Study with Continued Positive Outcomes Through 24 months
Published: 2021-11-09 (Crawled : 21:00) - biospace.com/
TELA | $4.47 0.0% 85K
|
Health Technology
|
| O: 2.36%
H: 0.0%
C: 0.0%
positive
Foghorn Therapeutics Provides Third Quarter 2021 Corporate Update
Published: 2021-11-09 (Crawled : 21:00) - biospace.com/
FHTX | $5.21 0.97% 0.96% 110K
|
Health Technology
|
| O: -1.26%
H: 3.69%
C: 1.2%
therapeutics
scPharmaceuticals Inc. Reports Third Quarter 2021 Financial Results and Provides Business Update
Published: 2021-11-09 (Crawled : 21:00) - biospace.com/
SCPH | $4.51 -2.17% -2.22% 92K
|
Health Technology
|
| O: -3.94%
H: 0.0%
C: 0.0%
financial results results
Evaxion Biotech Announces Q3 2021 Financial Results and Provides Business Update
Published: 2021-11-09 (Crawled : 21:00) - biospace.com/
EVAX | $4.06 -1.93% -1.97% 10K
|
Manufacturing
| Email alert
Add to watchlist
financial results results biotech iot
Medicenna Therapeutics to Present at Stifel’s Virtual Healthcare Conference
Published: 2021-11-09 (Crawled : 20:00) - biospace.com/
MDNA | $0.157 -0.32% 1.3M
|
Health Technology
|
| O: -1.4%
H: 0.19%
C: -4.25%
conference therapeutics
Impel NeuroPharma to Present at the Guggenheim Securities 3rd Annual Neuro/Immunology Conference
Published: 2021-11-09 (Crawled : 20:00) - biospace.com/
IMPL 4 | $0.2411 -77.19% 860K
|
Professional, Scientific, and T...
|
| O: -0.44%
H: 0.0%
C: 0.0%
immunology conference
Mereo BioPharma to Present at Two Upcoming Investor Conferences
Published: 2021-11-09 (Crawled : 20:00) - biospace.com/
RARE F | $44.26 -1.88% -1.92% 670K
|
Health Technology
|
| O: -0.21%
H: 0.0%
C: 0.0%
MREO | $2.785 0.18% 0.18% 570K
|
Health Technology
|
| O: -1.42%
H: 0.0%
C: 0.0%
biopharma conference
Tempest to Present at Two Upcoming Investor Conferences in November
Published: 2021-11-09 (Crawled : 20:00) - biospace.com/
TPST | $3.43 0.29% 0.29% 650K
|
Manufacturing
|
| O: 0.99%
H: 0.0%
C: 0.0%
pest conference
Rain Therapeutics Plans Phase 2 Merkel Cell Carcinoma Clinical Trial (MANTRA-3) of Milademetan
Published: 2021-11-09 (Crawled : 20:00) - biospace.com/
RAIN | $1.21 0.0% 3.7M
|
Manufacturing
|
| O: 0.36%
H: 0.0%
C: 0.0%
phase 2 trial cell carcinoma
Athenex Announces Exclusive License Agreement with National Cancer Institute to Utilize T Cell Receptors Targeting Mutated p53, KRAS, and EGFR for the Development of Autologous and Allogeneic Cell Therapies
Published: 2021-11-09 (Crawled : 20:00) - biospace.com/
ATNX | $0.2031 -7.78% 1.9M
|
Health Technology
|
| O: -1.25%
H: 0.63%
C: -5.91%
cancer license t-cell
Oklahoma’s Highest Court Overturns Landmark Opioid Verdict Against J&J
Published: 2021-11-09 (Crawled : 20:00) - biospace.com/
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: -0.59%
H: 0.0%
C: 0.0%
opioid
Immutep Announces Publication of AIPAC, TACTI-002 and TACTI-003 Abstracts for SITC 2021 Annual Meeting & AIPAC Global Webcast Details
Published: 2021-11-09 (Crawled : 19:00) - biospace.com/
IMMP | $2.59 3.19% 3.09% 1.4M
|
Health Technology
|
| O: 5.26%
H: 0.0%
C: -25.6%
Immutep Reports Improved and Statistically Significant Survival Benefit for Three Key Patient Groups in Final Phase IIb AIPAC Study Results in Metastatic Breast Cancer
Published: 2021-11-09 (Crawled : 19:00) - biospace.com/
IMMP | $2.59 3.19% 3.09% 1.4M
|
Health Technology
|
| O: 5.26%
H: 0.0%
C: -25.6%
results cancer breast cancer metastatic breast cancer
Medtronic to announce financial results for its second quarter of fiscal year 2022
Published: 2021-11-09 (Crawled : 19:00) - biospace.com/
MDT | $80.38 -1.12% 0.0% 5M
|
Health Technology
|
| O: 0.23%
H: 0.0%
C: 0.0%
financial results results
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.